Joi B Carter

Joi B Carter, MD is an Associate Professor of Dermatology at the Geisel School of Medicine at Dartmouth. She holds multiple leadership positions including Director of the High Risk Skin Cancer Clinic, Dermatology Residency Program Director, and Vice Chair of Education for the Department of Dermatology. Dr. Carter is affiliated with the Dartmouth Cancer Center and maintains clinical specialties in cutaneous oncology and high-risk skin cancer management.

Dr. Carter's educational background includes a B.A. from College of the Holy Cross, an M.D. from Dartmouth Medical School, an Internal Medicine internship at Beth Israel Deaconess Medical Center, Dermatology residency at Dartmouth-Hitchcock Medical Center, and a Cutaneous Oncology fellowship at Brigham and Women's Hospital and Dana Farber Cancer Institute.

Her research focuses on cutaneous oncology with particular expertise in cutaneous T-cell and B-cell lymphomas, high-risk skin cancer, cutaneous care of transplant recipients, and melanoma. Dr. Carter leads the High Risk Skin Cancer Clinic and specializes in management of complex skin cancer cases, particularly in immunocompromised patients.

Analysis of Dr. Carter's recent publications reveals a strong focus on cutaneous squamous cell carcinoma research, with particular emphasis on risk stratification, metastasis prediction, and treatment outcomes. Her work frequently involves multicenter collaborations and contributes to clinical guidelines in dermatological oncology, especially regarding high-risk skin cancer management and cutaneous lymphomas.

Dr. Carter serves as Dermatology Residency Program Director, overseeing the training of future dermatologists with a focus on oncology and complex skin disease management. Her leadership extends to the Vice Chair of Education role for the Department of Dermatology, where she shapes educational programs and curriculum development.

She directs the High Risk Skin Cancer Clinic and maintains affiliations with the Dartmouth Cancer Center. Dr. Carter also operates specialized clinics focused on cutaneous lymphoma and high-risk skin cancer, with dedicated websites for these clinical services.